Aktieselskabet Schouw & Co.
Schouw & Co. share buy-back programme, week 19 2025
Schouw & Co. share buy-back programme, week 19 2025
On 5 May 2025, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 20 of 2 May 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 120 million during the period 5 May to 31 December 2025.
The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).
| Trading day | No. of shares | Average price | Amount | ||
| Monday, 5 May 2025 | 1,800 | 572.35 | 1,030,230 | ||
| Tuesday, 6 May 2025 | 1,900 | 561.47 | 1,066,793 | ||
| Wednesday, 7 May 2025 | 1,900 | 557.77 | 1,059,763 | ||
| Thursday, 8 May 2025 | 1,900 | 563.45 | 1,070,555 | ||
| Friday, 9 May 2025 | 1,900 | 564.94 | 1,073,386 | ||
| In the period 5 May 2025 - 9 May 2025 | 9,400 | 563.91 | 5,300,727 | ||
| Following the above transactions, Schouw & Co. holds a total of 2,051,393 treasury shares corresponding to 8.21% of the total share capital of 25,000,000 shares. | |||||
Aktieselskabet Schouw & Co.
Jørgen Dencker Wisborg, Chairman
Jens Bjerg Sørensen, President, telephone number +45 86 11 22 22
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
SkiStar AB13.12.2025 16:00:00 CET | Press release
Bulletin from Annual General Meeting of SkiStar AB
Robex Resources Inc.13.12.2025 06:31:43 CET | Press release
Robex Files Addendum to Information Circular in Connection With Amendment to Arrangement Agreement With Predictive Discovery
Teva Pharmaceutical Industries Ltd12.12.2025 22:30:00 CET | Press release
Teva Releases Q4 2025 Aide Memoire
Teva Pharmaceutical Industries Ltd12.12.2025 22:30:00 CET | Press release
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
Ingredion Incorporated12.12.2025 22:06:36 CET | Press release
Ingredion Incorporated Declares Quarterly Dividend of $0.82 Per Share
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom